Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Article Type
Facet Toggle
Time Frame
Facet Toggle
WORKING PAPERS
February 23, 2016
Controlling healthcare costs while promoting maximum health impact in the recipient countries is one the biggest challenges for global health donors. This paper views global health donors as the regulators of monopolistic service providers, and explores potential optimal fund payment systems under a...
Feb
23
2016
3:30—4:30 PM
February 19, 2016
The Institute for Disease Modeling conducts quantitative research aimed at disease eradication through the application of tools such as statistical and individual-based modeling. This talk will provide an overview of the Institute, and then focus on several vignettes that highlight how modelin...
Blog Post
December 15, 2015
Those who follow CGD will be familiar with our branded meme: “Cash on Delivery” aid, or COD. Many are enthusiastic about COD’s potential to revolutionize aid effectiveness. Yet within some global development organizations, leadership and staff alike express common concerns: is...
REPORTS
December 15, 2015
Founded in 2002, the Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) is one of the world’s largest multilateral health funders, disbursing $3–$4 billion a year across 100-plus countries. Many of these countries rely on Global Fund monies to finance their respective ...
Blog Post
December 01, 2015
As it does every year at this time, UNAIDS has released its World AIDS Day report. With five out of seven HIV infected people living in Africa, it is appropriate that the report is released here at the International Conference on AIDS and STIs in Africa (ICASA) in Harare, Zimbabwe.
Oct
8
2015
2:30—4:00 PM
October 06, 2015
Global financial resources for health have substantially increased over the period of the MDGs but are now steady or declining. Domestic resources in low- and middle-income countries may not be able to keep up with demand for treatment needs, let alone other prevention services. In this context, the...
Blog Post
September 23, 2015
You’ve probably already heard about the pharma outrage du jour. In short: start-up Turing Pharmaceuticals, led by combative ex-hedge fund manager Martin Shkreli, recently acquired Daraprim, a 60+ year-old drug to treat a parasitic infection called toxoplasmosis –...
Sep
29
2015
12:30—2:00 PM
September 22, 2015
The world recently reached a milestone in the fight against HIV/AIDS: 15 million people around the globe now have access to life-saving antiretroviral therapy (ART). In 2001, only 1 million people had such access. This has resulted in tremendous gains in population health and life expectancy for HIV...
WHITE HOUSE AND THE WORLD POLICY BRIEFS
July 20, 2015
Remarkable progress has been made in the global fight against HIV/AIDS. The number of people receiving treatment in low- and middle-income countries increased from 300,000 in 2003 to 13.7 million in 2015, including 7 million supported by the United States. These gains are primarily attributable to ...